Founded in 2015, Amiko is growing to become a global provider of digital medicines
About Amiko Digital Health Limited
Amiko has the ambition to offer a full range of technologies to collect data on delivery systems usage, including inhalers, nasal sprays, nebulizers, injectables, or pharmaceutical primary packaging. Our technology platforms are:
Proprietary and Patent Protected
Designed for add-on or integrated devices
Ideally suited for low-cost, low-power solutions
Amiko’s flagship product is Respiro®, a digital therapeutic solution that enables advanced tracking of respiratory medication use for improved adherence and treatment effectiveness.
Reply is a leading Consulting, Systems Integration and Digital Services company. Reply is listed on Borsa Italiana SpA since December 2000. In 2016, Reply recorded over $1 Billion in revenue.
Sanner develops, manufactures, and markets plastic packaging and components for pharmaceutical, medical, and household products, with the knowhow of over 55 years on the market. In 2016, Sanner recorded over $100 Million in sales.
Salisbury House, 31 Finsbury Circus, London, UK
Via Washington, 105,